• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number 04625358003
Device Problems Incorrect Or Inadequate Test Results (2456); Non Reproducible Results (4029)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 06/15/2018
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).Unique identifier (udi)#: (b)(4).
 
Event Description
The patient stated that he received erroneous results when testing with coaguchek xs meter serial number (b)(4).The patient measured the following values within 2 hours when testing capillary blood samples with the meter: 4.9 inr, 6.5 inr, and 5.7 inr.No adverse events were alleged to have occurred with the patient.The patient's condition is currently very good.The patient's therapeutic range is 3.1 - 3.5 inr.The patient does not have "ass", does not take antibiotics, does not take pain killers, and does not use disinfectants.The patient suffered a stroke 3 years ago and the therapeutic range of the patient was changed at that time after consultation with the doctor.The patient's prior therapeutic range was 2.5 - 3.0 inr.The patient's product was requested for investigation.Relevant retention test strips (lot 286321) were tested in comparison with the master lot.For this purpose two human blood samples from marcumar donors and two internal reference meters were used.Retention samples were within specifications.No error messages occurred.Upon review of the meter memory, the complained values are each dated (b)(6) 2003 and were measured at the following times: 4.9 inr at 11:13; 5.7 inr at 11:28; 6.5 inr at 11:42.In the memory, there is a value of 5.9 inr measured at 00:57 on (b)(6) 2018.The following discrepancies were also observed in the meter memory: on (b)(6) 2002 at 12:43, the patient had a value of 3.3 inr.On (b)(6) 2002 at 12:51, the patient had a value of 2.3 inr.On (b)(6) 2002 at 13:29, the patient had a value of 3.8 inr.On (b)(6) 2002 at 13:35, the patient had a value of 2.7 inr.On (b)(6) 2002 at 10:20, the patient had a value of 3.4 inr.On (b)(6) 2002 at 10:31, the patient had a value of 2.6 inr.On (b)(6) -2003 at 12:48, the patient had a value of 2.9 inr.On (b)(6) 2003 at 12:53, the patient had a value of 1.0 inr.On (b)(6) 2003 at 11:52, the patient had a value of 1.5 inr.On (b)(6) 2003 at 11:58, the patient had a value of 3.2 inr.On (b)(6) 2003 at 11:07, the patient had a value of 3.0 inr.On (b)(6) 2003 at 11:17, the patient had a value of 1.9 inr.On (b)(6) 2003 at 07:29, the patient had a value of 1.0 inr.On (b)(6) 2003 at 07:40, the patient had a value of 2.5 inr.
 
Manufacturer Narrative
The patient's meter and strips was returned for investigation.The returned meter and strips were tested in comparison to a retention meter and master lot strips.Human blood samples from warfarin donors were used.Testing results: donor 1: retention meter with master lot strips: 2.9 inr, customer meter with customer strips: 2.9 inr.Donor 2: retention meter with master lot strips: 2.3 inr, customer meter with customer strips: 2.4 inr.The maximum difference between measurements with the same blood sample was 4%.Returned customer material and retention material comply with the specification.Complained lot and meter have fulfilled the release criterion of product control.
 
Manufacturer Narrative
Extensive measurements have shown higher deviations for coaguchek values > 4.5 inr compared to a laboratory method.Therefore, the customer allegation has been substantiated.A product problem has been found for coaguchek values > 4.5 inr, which was the case in this complaint.This can be traced back to the calibration of the complained test strips to the who standard rtf/16.For measurements > 4.5 inr.The customer is advised to contact the physician and perform a measurement with a laboratory method.Roche diagnostics has issued a recall for this issue.Correction/removal report no.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK ® XS SYSTEM
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key7651426
MDR Text Key113187297
Report Number1823260-2018-02147
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
PMA/PMN Number
K062925
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,foreign
Type of Report Initial,Followup,Followup
Report Date 10/05/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date06/30/2019
Device Catalogue Number04625358003
Device Lot Number28632111
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/25/2019
Initial Date Manufacturer Received 06/15/2018
Initial Date FDA Received06/29/2018
Supplement Dates Manufacturer Received06/15/2018
06/15/2018
Supplement Dates FDA Received08/03/2018
10/05/2018
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction Number1823260-08/30/18-005-C
Patient Sequence Number1
Treatment
ARTIFICIAL HEART VALVE; BISOPROL; LEXIUM; MARCUMAR
Patient Age79 YR
-
-